178 related articles for article (PubMed ID: 9605753)
1. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
Thompson PA; Shields PG; Freudenheim JL; Stone A; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Kadlubar FF; Ambrosone CB
Cancer Res; 1998 May; 58(10):2107-10. PubMed ID: 9605753
[TBL] [Abstract][Full Text] [Related]
2. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
3. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
[TBL] [Abstract][Full Text] [Related]
7. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.
Bergman-Jungeström M; Wingren S
Br J Cancer; 2001 Sep; 85(6):859-62. PubMed ID: 11556837
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Goodman JE; Lavigne JA; Hengstler JG; Tanner B; Helzlsouer KJ; Yager JD
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1373-6. PubMed ID: 11142424
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
[TBL] [Abstract][Full Text] [Related]
14. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
[TBL] [Abstract][Full Text] [Related]
16. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis.
Pooley EC; Fineberg N; Harrison PJ
Mol Psychiatry; 2007 Jun; 12(6):556-61. PubMed ID: 17264842
[TBL] [Abstract][Full Text] [Related]
17. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]